BiotechTube
Home/BioGenCell/Michal Fisher
MF

Michal Fisher

Chief Business Officer

BioGenCell

Therapeutic Areas

VascularCardiovascularNeurologyOncologyImmunologyRegenerative Medicine

BioGenCell Pipeline

DrugIndicationPhase
BGC101Chronic Limb‑Threatening Ischemia (CLTI)Phase 2
BGC10XBroad Microvascular Unmet NeedsPreclinical

Leadership Team at BioGenCell

YP
Yael Porat, PhD
Founder, CEO & CSTO
EP
Eyal Peleg, CPA, MBA
Founder, CFO
SC
Sharon Cohen
VP R&D
View full BioGenCell profile